Join
Live feed
·
PRReleasevia Quantisnow
Health Sciences Acquisitions Corporation 2 logo

Orchestra BioMed™ Announces Presentation of Positive Long-Term Clinical Results from MODERATO II Control Patients Crossover Extension Study of BackBeat CNT™ at TCT 2022

ByQuantisnow·Wall Street's wire, on your screen.
HSAQ· Health Sciences Acquisitions Corporation 2
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HSAQ (Health Sciences Acquisitions Corporation 2) and more on Quantisnow.